Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
CT ›
CTX120
Trademark search for:
CTX120
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-02-11 — Application filed
2019-03-05 — Application filed
2019-04-19 — Assigned to examiner
2019-04-24 — Final disposition recorded
2019-04-24 — Final disposition recorded
2019-04-24 — Final disposition recorded
2019-04-26 — Teas revoke/app/change addr of atty/dom rep received
2019-04-26 — Attorney/dom.rep.revoked and/or appointed
2019-08-01 — Office action issued
2019-08-01 — Correspondence received in law office
2019-08-02 — Teas/email correspondence entered
2019-08-06 — Approved for pub - principal register
2019-08-13 — Assigned to lie
2019-08-28 — Notification of notice of publication e-mailed
2019-09-17 — Published for opposition
2019-09-17 — Official gazette publication confirmation e-mailed
2019-11-12 — Noa e-mailed - sou required from applicant
2020-05-11 — Sou teas extension received
2020-05-11 — Sou extension 1 filed
2020-05-11 — Sou extension 1 granted
2020-05-13 — Notice of approval of extension request e-mailed
2020-08-05 — Teas revoke/app/change addr of atty/dom rep received
2020-08-05 — Attorney/dom.rep.revoked and/or appointed
2020-08-05 — Teas change of domestic representatives address
2020-08-05 — Teas change of correspondence received
2020-11-11 — Sou teas extension received
2020-11-11 — Sou extension 2 filed
2020-11-11 — Sou extension 2 granted
2020-11-13 — Notice of approval of extension request e-mailed
2021-04-07 — Teas change of correspondence received
2021-04-07 — Applicant/correspondence changes (non-responsive) entered
2021-04-07 — Teas change of owner address received
2021-04-14 — Sou teas extension received
2021-04-14 — Sou extension 3 filed
2021-04-14 — Sou extension 3 granted
2021-04-16 — Notice of approval of extension request e-mailed
2021-11-01 — Sou teas extension received
2021-11-01 — Sou extension 4 filed
2021-11-01 — Sou extension 4 granted
2021-11-03 — Notice of approval of extension request e-mailed
2022-04-07 — Sou teas extension received
2022-04-07 — Sou extension 5 filed
2022-04-14 — Case assigned to intent to use paralegal
2022-04-14 — Sou extension 5 granted
2022-04-15 — Notice of approval of extension request e-mailed
2022-12-19 — Application abandoned
2022-12-19 — Application abandoned
2022-12-19 — Final status recorded
Owner Information
CRISPR Therapeutics AG
ZUG V8 CH
CRISPR Therapeutics AG
Basel CH
Correspondent
Tiffany D. Gehrke Marshall Gerstein & Borun LLP 233 S. Wacker Drive Suite 6300 Chicago, IL 60606
Filing Details
Filing Date:
2019-02-11
Status Date:
2022-12-19
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.